⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CURX News
Curanex Pharmaceuticals Inc Common Stock
Form 8-K
sec.gov
CURX
Form 8-K
sec.gov
CURX
Form 8-K
sec.gov
CURX
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
prnewswire.com
CURX
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
prnewswire.com
CURX
Form 8-K
sec.gov
CURX
Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission
globenewswire.com
CURX
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
prnewswire.com
CURX
Form 8-K
sec.gov
CURX
CURX Investors Have Opportunity to Join Curanex Pharmaceuticals Inc Fraud Investigation with the Schall Law Firm
globenewswire.com
CURX